Aspyre Lung is a targeted biomarker panel of 114 genomic variants across 11 guideline-recommended genes with simultaneous DNA and RNA for non–small cell lung cancer (NSCLC). In this study, we ...

A promising new study has identified a highly accurate, non-invasive method to diagnose non-small cell lung cancer (NSCLC) ...

e20025Background: Lung cancer remains a leading cause of cancer-related mortality worldwide. Early detection significantly improves survival rates. In our previous study, we developed a machine ...

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a proposed collaboration with Guardant Health, I ...

In this groundbreaking study funded by Cancer Research UK, co-authors Black and Bartha et al. highlight advancements in lung cancer detection using NeXT Personal®, an ultra-sensitive personalized ...

Researchers say findings provide compelling evidence underscoring the potential of electric-field molecular fingerprinting for minimally invasive disease detection.

Building on these insights, the team developed a machine learning tool to predict how patients with advanced lung cancer might respond to immunotherapy.

Edgardo S. Santos, MD, FACP, FASCO, emphasized the need to eliminate the stigma around smoking in lung cancer, highlighted the importance of early detection and discussed how advances in precision ...

Lung cancer is the leading cause of cancer-related death in the U.S., but recent guidelines, if followed, can make it possible for smokers to avoid becoming part of that statistic.

A groundbreaking medical machine could be the key to early detection for lung cancer. Politician suffers stroke live on air during interview NRL fans react after Allana Ferguson backs Greg Inglis ...